Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Baraclude 0.5 mg Tablet
Manufacturer/Marketed By : BMS India Pvt Ltd
$8.44 $6.58
Baraclude 0.5 mg Tablet is an effective antiviral medication specifically designed for the management of chronic hepatitis B virus (HBV) infections in adults, as well as in children and adolescents...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Entecavir 0.5 mg
Active Pharmaceutical Ingredient
Baraclude 0.5 mg Tablet
$8.44
$6.58
Baraclude 0.5 mg Tablet is an effective antiviral medication specifically designed for the management of chronic hepatitis B virus (HBV) infections in adults, as well as in children and adolescents aged 2 to under 18 years. This medication works by inhibiting the replication of the hepatitis B virus, thereby helping to protect the liver from further damage and maintaining its function. Baraclude is suitable for individuals with varying degrees of liver health, including those with liver impairment, although careful monitoring is essential. Patients using Baraclude should be aware of potential risks, such as the possibility of lactic acidosis or severe liver issues if treatment is discontinued abruptly. It’s crucial to follow the prescribed dosage and consult with a healthcare professional regularly to ensure optimal results and safety. As a part of a comprehensive treatment plan, Baraclude contributes significantly to improving the quality of life for those affected by chronic HBV infections. Always discuss any concerns or side effects with your doctor to ensure a safe and effective treatment journey.
Active Pharmaceutical Ingredient
Uses
• Baraclude 0.5 mg tablet is primarily used in the management of chronic hepatitis B, a long-lasting infection caused by the hepatitis B virus (HBV). This medication helps to suppress viral replication in the liver, thereby reducing the risk of severe liver complications. Patients typically take Baraclude 0.5 mg tablet as part of a long-term treatment plan to maintain liver health. Regular monitoring is essential to assess the effectiveness of the therapy.
• The use of Baraclude 0.5 mg tablet can significantly lower the likelihood of liver damage associated with chronic hepatitis B infection. By effectively controlling the virus, it helps to prevent conditions such as cirrhosis and liver cancer. This is particularly important for individuals who may be at higher risk due to factors like age or pre-existing liver conditions. Baraclude 0.5 mg tablet is often recommended for patients with elevated liver enzymes indicating active disease.
• In addition to its antiviral effects, Baraclude 0.5 mg tablet plays a crucial role in improving the overall quality of life for individuals living with chronic hepatitis B. By managing the virus, it can alleviate symptoms and reduce the burden of the disease. Patients may experience fewer complications and a better prognosis when adhering to their prescribed treatment with Baraclude 0.5 mg tablet. It is an integral part of a comprehensive care approach for hepatitis B management.
• Baraclude 0.5 mg tablet is also utilized in specific cases where the hepatitis B virus has developed resistance to other antiviral treatments. This medication offers an alternative option for patients who may not have responded adequately to previous therapies. By providing a different mechanism of action, Baraclude 0.5 mg tablet can help regain control over the viral infection. Healthcare providers often consider it for patients who require a more effective treatment strategy.
Benefits
Baraclude 0.5 mg Tablet helps to reduce the amount of Hepatitis B Virus in the body, which can help slow the progression of liver damage caused by the virus. Baraclude 0.5 mg can help whoever is suffering from liver disease. It can improve liver function in people with chronic hepatitis B virus infection. Side effects of Baraclude 0.5 mg Tablet may decrease the risk of complications, including liver scarring (cirrhosis), liver cancer, and liver failure. Benefits of Baraclude 0.5 mg Tablet may reduce the symptoms such as fatigue, abdominal pain, and loss of appetite and improve the quality of life.
Side Effects
Side effects of Baraclude 0.5 mg Tablet may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Headache
• Nausea
• Rash
• Vomiting
• Fatigue
• Stomach pain
• Diarrhea
Common Side Effects
• Lactic acidosis
• Liver problems
How To Use
Benefits of Baraclude 0.5 mg Tablet may be taken with or without food. Swallow the tablet whole with a full glass of water. Do not crush, chew, or open the tablet. If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and take the next dose at the regular time. Do not take two doses at the same time to make up for a missed dose.
Safety Advice
• Alcohol: It is generally not recommended to drink alcohol while taking Baraclude 0.5 mg Tablet. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Uses of Baraclude 0.5 mg Tablet should be used with caution in patients with kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Baraclude 0.5 mg and report any unusual symptoms or changes in kidney function to their doctor. The dose of How Baraclude 0.5 mg Tablet works may need to be adjusted in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Uses of Baraclude 0.5 mg Tablet. Side effects of Baraclude 0.5 mg Tablet may pass into breast milk and harm the infant. If you are breastfeeding and taking Baraclude 0.5 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Baraclude 0.5 mg Tablet is safe to use in patients with liver disease. No dose adjustment of Baraclude 0.5 mg is recommended. If you experience any side effects, please consult your doctor.
• Pregnancy: Use of Side effects of Baraclude 0.5 mg Tablet may be unsafe during pregnancy, as animal studies indicate that it may harm the developing fetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Baraclude 0.5 mg during pregnancy. Your doctor will be able to help you make the best decision for your health and that of your baby.
• Driving: Benefits of Baraclude 0.5 mg Tablet may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions, such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Baraclude 0.5 mg.
Disclaimer
Sidmex Inovia strives to provide accurate and reliable information; however, all content on this website, including product descriptions and compositions, is for informational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment.
Users are advised to consult a qualified healthcare professional before making any medical decisions. The information provided should not be used for self-diagnosis or self-medication.
All products listed are intended strictly for B2B and bulk inquiry purposes only. Sidmex Inovia does not promote direct consumer use and aims to support, not replace, the healthcare professional–patient relationship.
Product names, trademarks, and brands belong to their respective owners, and their use does not imply any affiliation or endorsement. Sidmex Inovia shall not be held responsible for any consequences arising from the use of the information provided on this website.